SCHEMBL22970163

SCHEMBL22970163

c1ccc(-c2ccc3ccc4ccc(-c5cccc(-c6ccc7ccc(-c8ccc9ccc(-c%10cccc(-c%11ccccn%11)c%10)nc9c8)nc7c6)c5)nc4c3n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.44
IGF1R P08069 2/20 0.41
TOP1 P11387 4/20 0.41
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PI4KA P42356 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2A6 P11509 1/20 0.40
MAPK1 P28482 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PARP1 P09874 1/20 0.39
NPC1 O15118 2/20 0.39
AR P10275 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24454138 0.97 IGF1R (0.42) DHODHIGF1RTOP1PIK3CDPIK3CA
SCHEMBL22282016 0.96 KDM4E (0.44) DHODHIGF1RTOP1RAB9AMEN1
SCHEMBL22970534 0.96 KDM4E (0.44) DHODHIGF1RTOP1RAB9AMEN1
SCHEMBL24475484 0.92 TOP1 (0.43) DHODHTOP1PIK3CDPIK3CAPI4KA
SCHEMBL22970524 0.92 IGF1R (0.41) DHODHIGF1RTOP1PIK3CDPIK3CA
SCHEMBL22970530 0.92 TOP1 (0.43) DHODHIGF1RTOP1PIK3CDPIK3CA
SCHEMBL22281845 0.92 TOP1 (0.43) DHODHIGF1RTOP1RAB9AMEN1
SCHEMBL22282134 0.92 TOP1 (0.43) DHODHIGF1RTOP1RAB9AMEN1
SCHEMBL24475447 0.91 TOP1 (0.42) IGF1RTOP1PIK3CDPIK3CAPI4KA
SCHEMBL24454311 0.91 IGF1R (0.41) DHODHIGF1RTOP1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220165962-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME LT MATERIALS CO., LTD. (KR) 2022-05-26 US disclosed
WO-2021025356-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME 엘티소재주식회사 2021-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220165962-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CRY1, CYP1A1, CYP1B1 DHODH 222/4885IGF1R 2470/4885TOP1 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.